# First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

> clinical trial · VERIFIED · 2026-09-01

Status: ACTIVE_NOT_RECRUITING · Sponsor: Daiichi Sankyo Co., Ltd. · Condition: Hormone Receptor Positive Breast Cancer

- Company: Daiichi Sankyo Co., Ltd.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT03401385

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.